Clinical Trial Update: A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine) [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluating impulsivity in Huntington's disease patients treated with Xenazine (tetrabenazine).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Xenazine (tetrabenazine)

Snippet

Sponsor: William Ondo, MD | Conditions: Huntington's Disease | Phase 4 | Status: UNKNOWN